- Home
- IMXI vs AUTL Comparison
IMXI vs AUTL Comparison
Compare IMXI & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMXI | AUTL |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.2M | 433.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | IMXI | AUTL |
|---|---|---|
| Price | $15.42 | $1.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $16.67 | $8.33 |
| AVG Volume (30 Days) | 224.1K | ★ 2.5M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $625,123,000.00 | $51,128,000.00 |
| Revenue This Year | N/A | $658.11 |
| Revenue Next Year | $0.95 | $91.34 |
| P/E Ratio | $11.93 | ★ N/A |
| Revenue Growth | N/A | ★ 406.67 |
| 52 Week Low | $8.58 | $1.11 |
| 52 Week High | $21.41 | $2.80 |
Technical Indicators
Market Signals| Indicator | IMXI | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 62.13 | 57.88 |
| Support Level | $15.32 | $1.63 |
| Resistance Level | $15.42 | $1.79 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 36.21 | 59.09 |
Price Performance
Historical ComparisonAbout IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.